Big Gain For Statera Biopharma Inc.
Fri, Dec 08, 2023 at 07:37 PM
Statera Biopharma Inc. (STAB:NASDAQ) soared at $0, representing a gain of 33.3%. On Fri, Dec 08, 2023, STAB:NASDAQ touched a New 2-Week High of $0. From Mon, Nov 27, 2023, the stock recorded 0.00% Up Days and 0.00% Green Days
About Statera Biopharma Inc. (STAB:NASDAQ)
Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 400%
- MBIA Inc. (MBI:NYSE), 81.84%
- Intensity Therapeutics Inc. (INTS:NASDAQ), 63.81%
- Rubius Therapeutics, Inc. (RUBY:NASDAQ), 56.25%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 45.48%
- Assure Holdings Corp. (IONM:NASDAQ), 34.7%
- Statera Biopharma Inc. (STAB:NASDAQ), 33.33%
- ALX Oncology Holdings Inc. (ALXO:NASDAQ), 32.54%
- Azitra Inc (AZTR:NYSEMKT), 28.57%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 27.64%